Insight: Prolonged vaginal bleeding during central precocious puberty therapy with a long-acting gonadotropin-releasing hormone agonist: A proposed mechanism and management plan

Journal of Pediatric and Adolescent Gynecology

Volumn 24, Issue 6, 2011, Pages 365-367

  Kauschansky, Arieh ^a   Orvieto, Raoul ^b   Yeshaya, Arie ^c   Shterntal, Boris ^a   Naor, Zvi ^a  

^a TEL AVIV UNIVERSITY   (Israel)

^b BARZILAI MEDICAL CENTER   (Israel)

^c RABIN MEDICAL CENTER   (Israel)

Author keywords

GnRH agonist; Precocious puberty; Prostaglandins; Vaginal bleeding

Indexed keywords

GONADORELIN AGONIST; PROSTAGLANDIN;

ARTICLE; CENTRAL PRECOCIOUS PUBERTY; ENDOMETRIUM; HUMAN; PRECOCIOUS PUBERTY; PRIORITY JOURNAL; SEXUAL MATURATION; TREATMENT PLANNING; VAGINA BLEEDING;

CYCLOOXYGENASE 2; DINOPROSTONE; FEMALE; GONADOTROPIN-RELEASING HORMONE; HUMANS; PUBERTY, PRECOCIOUS; RECEPTORS, PROSTAGLANDIN; SIGNAL TRANSDUCTION; UTERINE HEMORRHAGE;

EID: 81255157697     PISSN: 10833188     EISSN: 18734332     Source Type: Journal    
DOI: 10.1016/j.jpag.2011.06.007     Document Type: Article

References (13)

1. Yeshaya A., Kauschansky A., Orvieto R., et al. Prolonged vaginal bleeding during central precocious puberty therapy with a long-acting gonadotropin-releasing hormone agonist. Acta Obstet Gynecol Scand 1998, 77:327.
2. Seminara S., Nanni L., Generoso M., et al. Effect of treatment with cyproterone acetate on uterine bleeding at the beginning of GnRH analogue therapy in girls with idiopathic central precocious puberty. Horm Res Paediatr 2010, 73:386.
3. Swaenepoel C., Chaussain J.L., Roger M. Long-term results of long-acting luteinizing-hormone-releasing hormone agonist in central precocious puberty. Horm Res 1991, 36:126.
4. Naor Z., Jabbour H.N., Naidich M., et al. Reciprocal cross talk between gonadotropin-releasing hormone (GnRH) and prostaglandin receptors regulates GnRH receptor expression and differential gonadotropin secretion. Mol Endocrinol 2007, 21:524.
5. McArdle C.A., Franklin J., Green L., et al. Signalling, cycling and desensitisation of gonadotrophin-releasing hormone receptors. J Endocrinol 2002, 173:1.
6. Naor Z. Signaling by G-protein-coupled receptor (GPCR): studies on the GnRH receptor. Front Neuroendocrinol 2009, 30:10.
7. Jabbour H.N., Sales K.J. Prostaglandin receptor signalling and function in human endometrial pathology. Trends Endocrinol Metab 2004, 15:398.
8. Smith S.K., Abel M.H., Kelly R.W., et al. Prostaglandin synthesis in the endometrium of women with ovular dysfunctional uterine bleeding. Br J Obstet Gynaecol 1981, 88:434.
9. Rees M.C., Anderson A.B., Demers L.M., et al. Prostaglandins in menstrual fluid in menorrhagia and dysmenorrhoea. Br J Obstet Gynaecol 1984, 91:673.
10. Sales K.J., Jabbour H.N. Cyclooxygenase enzymes and prostaglandins in pathology of the endometrium. Reproduction 2003, 126:559.
11. Battersby S., Boddy S.C., Critchley H.O., et al. Expression and localization of endothelial monocyte-activating polypeptide II in the human endometrium across the menstrual cycle: regulation of expression by prostaglandin E(2). J Clin Endocrinol Metab 2002, 87:3928.
12. Perchick G.B., Jabbour H.N. Cyclooxygenase-2 overexpression inhibits cathepsin D-mediated cleavage of plasminogen to the potent antiangiogenic factor angiostatin. Endocrinology 2003, 144:5322.
13. Yoshimura Y., Nakamura Y., Oda T., et al. Effects of gonadotropin-releasing hormone agonists on meiotic maturation of follicle-enclosed oocytes in rabbits. Biol Reprod 1990, 43:1012.